Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
暂无分享,去创建一个
Iacopo Olivotto | Franco Cecchi | I. Olivotto | F. Cecchi | T. Brouwer | R. Knops | C. Fumagalli | L. O. Olde Nordkamp | Reinoud E Knops | Niccolo' Maurizi | Katia Baldini | Louise R A Olde Nordkamp | Carlo Fumagalli | Tom F Brouwer | K. Baldini | N. Maurizi
[1] D. Spodick,et al. Global T wave inversion: long-term follow-up. , 1993, Journal of the American College of Cardiology.
[2] Wojciech Zareba,et al. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. , 2008, Journal of the American College of Cardiology.
[3] Alexander H Maass,et al. An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, The New England journal of medicine.
[4] Martin J Schalij,et al. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. , 2011, Journal of the American College of Cardiology.
[5] Barry J Maron,et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.
[6] Barry J Maron,et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.
[7] M. Gold,et al. Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study , 2012, Journal of cardiovascular electrophysiology.
[8] L. Jordaens,et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. , 2012, Journal of the American College of Cardiology.
[9] D. Todd,et al. United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[10] F. Gaita,et al. Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study. , 2013, International journal of cardiology.
[11] Arthur A M Wilde,et al. The ICD for Primary Prevention in Patients With Inherited Cardiac Diseases: Indications, Use, and Outcome: A Comparison With Secondary Prevention , 2013, Circulation. Arrhythmia and electrophysiology.
[12] Rishi Arora,et al. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. , 2014, Heart rhythm.
[13] A. Wilde,et al. Which Patients Are Not Suitable for a Subcutaneous ICD: Incidence and Predictors of Failed QRS‐T‐Wave Morphology Screening , 2014, Journal of cardiovascular electrophysiology.
[14] Giuseppe Limongelli,et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.
[15] P. Lambiase,et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry , 2014, European heart journal.
[16] N. Hawkins,et al. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[17] B. Prendergast,et al. A meta-analysis of echocardiographic measurements of the left heart for the development of normative reference ranges in a large international cohort: the EchoNoRMAL study. , 2014, European heart journal cardiovascular Imaging.
[18] F. Rutten,et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.
[19] F. T. ten Cate,et al. Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy , 2015, Circulation. Arrhythmia and electrophysiology.
[20] Arthur A M Wilde,et al. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management. , 2015, International journal of cardiology.
[21] M. Schalij,et al. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications. , 2015, Heart rhythm.
[22] C. Autore,et al. Eligibility for the Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy , 2015, Journal of cardiovascular electrophysiology.